Advertisement
Screener

MESOBLAST LIMITED (MEOBF) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

MESOBLAST LIMITED Research and Development Expense

MESOBLAST LIMITED (MEOBF) reported Research and Development Expense of $46.16 million for the 6-month period ending 2025-12-31, per its 6-K filed 2026-02-27.

Financial Statements › Expense Statement › Operating Expenses

ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-02-27

  • MESOBLAST LIMITED research and development expense for the quarter ending 2023-06-30 was $32.32M, a 541.40% increase year-over-year.
  • MESOBLAST LIMITED research and development expense for the quarter ending 2023-03-31 was $7.07M, a 14.35% decline year-over-year.
  • MESOBLAST LIMITED research and development expense for the quarter ending 2022-12-31 was $7.68M, a 24.66% decline year-over-year.
  • MESOBLAST LIMITED research and development expense for the quarter ending 2022-09-30 was $5.74M, a 38.42% decline year-over-year.
Period endResearch And Development Expense 3 monthResearch And Development Expense 6 monthResearch And Development Expense 6 month as first filedResearch And Development Expense 9 monthResearch And Development Expense 12 monthResearch And Development Expense 12 month as first filed
2025-12-31$46.16M
6-K · filed 2026-02-27
2025-06-30$34.81M
20-F · filed 2025-08-29
2024-12-31$5.08M
6-K · filed 2026-02-27
$20.65M
6-K · filed 2025-02-27
2024-06-30$39.72M
20-F · filed 2025-08-29
$25.35M
20-F · filed 2024-08-29
2023-12-31$12.65M
6-K · filed 2025-02-27
2023-06-30$32.32M
derived: 20-F 12 month − 6-K 9 month · filed 2025-08-29
$39.39M
derived: sum of 2 quarters · filed 2025-08-29
$47.07M
derived: sum of 3 quarters · filed 2025-08-29
$52.82M
20-F · filed 2025-08-29
$27.19M
20-F · filed 2023-08-31
2023-03-31$7.07M
6-K · filed 2023-05-26
$14.75M
derived: sum of 2 quarters · filed 2023-05-26
$20.50M
6-K · filed 2023-05-26
$25.53M
derived: sum of 4 quarters · filed 2024-08-29
2022-12-31$7.68M
6-K · filed 2023-02-28
$13.43M
6-K · filed 2024-02-29
$18.47M
derived: sum of 3 quarters · filed 2024-08-29
$26.72M
derived: sum of 4 quarters · filed 2024-08-29
2022-09-30$5.74M
6-K · filed 2022-11-28
$10.78M
derived: sum of 2 quarters · filed 2024-08-29
$19.03M
derived: sum of 3 quarters · filed 2024-08-29
$29.23M
derived: sum of 4 quarters · filed 2024-08-29
2022-06-30$5.04M
derived: 20-F 12 month − 6-K 9 month · filed 2024-08-29
$13.29M
derived: sum of 2 quarters · filed 2024-08-29
$23.49M
derived: sum of 3 quarters · filed 2024-08-29
$32.81M
20-F · filed 2024-08-29
2022-03-31$8.25M
6-K · filed 2023-05-26
$18.45M
derived: sum of 2 quarters · filed 2023-05-26
$27.78M
6-K · filed 2023-05-26
$34.83M
derived: sum of 4 quarters · filed 2023-08-31
2021-12-31$10.20M
6-K · filed 2023-02-28
$19.53M
6-K · filed 2023-02-28
$26.58M
derived: sum of 3 quarters · filed 2023-08-31
$39.02M
derived: sum of 4 quarters · filed 2023-08-31
2021-09-30$9.33M
6-K · filed 2022-11-28
$16.38M
derived: sum of 2 quarters · filed 2023-08-31
$28.82M
derived: sum of 3 quarters · filed 2023-08-31
$43.06M
derived: sum of 4 quarters · filed 2023-08-31
2021-06-30$7.05M
derived: 20-F 12 month − 6-K 9 month · filed 2023-08-31
$19.50M
derived: sum of 2 quarters · filed 2023-08-31
$33.73M
derived: sum of 3 quarters · filed 2023-08-31
$53.01M
20-F · filed 2023-08-31
2021-03-31$12.44M
6-K · filed 2022-06-03
$26.68M
derived: sum of 2 quarters · filed 2022-06-03
$45.96M
6-K · filed 2022-06-03
$61.22M
derived: sum of 4 quarters · filed 2022-08-31
2020-12-31$14.24M
6-K · filed 2022-02-25
$33.52M
6-K · filed 2022-02-25
$48.78M
derived: sum of 3 quarters · filed 2022-08-31
$63.16M
derived: sum of 4 quarters · filed 2022-08-31
2020-09-30$19.28M
6-K · filed 2021-11-24
$34.54M
derived: sum of 2 quarters · filed 2022-08-31
$48.92M
derived: sum of 3 quarters · filed 2022-08-31
$63.08M
derived: sum of 4 quarters · filed 2022-08-31
2020-06-30$15.27M
derived: 20-F 12 month − 6-K 9 month · filed 2022-08-31
$29.64M
derived: sum of 2 quarters · filed 2022-08-31
$43.80M
derived: sum of 3 quarters · filed 2022-08-31
$56.19M
20-F · filed 2022-08-31
2020-03-31$14.38M
6-K · filed 2021-06-04
$28.53M
derived: sum of 2 quarters · filed 2021-06-04
$40.92M
6-K · filed 2021-06-04
$52.36M
derived: sum of 4 quarters · filed 2021-08-31
2019-12-31$14.15M
6-K · filed 2021-03-02
$26.54M
6-K · filed 2021-03-02
$37.98M
derived: sum of 3 quarters · filed 2021-08-31
$52.38M
derived: sum of 4 quarters · filed 2021-08-31
2019-09-30$12.39M
6-K · filed 2020-11-23
$23.82M
derived: sum of 2 quarters · filed 2021-08-31
$38.23M
derived: sum of 3 quarters · filed 2021-08-31
$53.72M
derived: sum of 4 quarters · filed 2021-08-31
2019-06-30$11.44M
derived: 20-F 12 month − 6-K 9 month · filed 2021-08-31
$25.84M
derived: sum of 2 quarters · filed 2021-08-31
$41.33M
derived: sum of 3 quarters · filed 2021-08-31
$59.81M
20-F · filed 2021-08-31
2019-03-31$14.41M
6-K · filed 2020-05-29
$29.89M
derived: sum of 2 quarters · filed 2020-05-29
$48.38M
6-K · filed 2020-05-29
$65.92M
derived: sum of 4 quarters · filed 2020-09-03
2018-12-31$15.49M
6-K · filed 2020-02-28
$33.98M
6-K · filed 2020-02-28
$51.52M
derived: sum of 3 quarters · filed 2020-09-03
$68.31M
derived: sum of 4 quarters · filed 2020-09-03
2018-09-30$18.49M
6-K · filed 2019-11-27
$36.03M
derived: sum of 2 quarters · filed 2020-09-03
$52.83M
derived: sum of 3 quarters · filed 2020-09-03
$69.05M
derived: sum of 4 quarters · filed 2020-09-03
2018-06-30$17.54M
derived: 20-F 12 month − 6-K 9 month · filed 2020-09-03
$34.34M
derived: sum of 2 quarters · filed 2020-09-03
$50.56M
derived: sum of 3 quarters · filed 2020-09-03
$65.93M
20-F · filed 2020-09-03
2018-03-31$16.80M
6-K · filed 2019-06-03
$33.02M
derived: sum of 2 quarters · filed 2019-06-03
$48.39M
6-K · filed 2019-06-03
2017-12-31$16.22M
6-K · filed 2019-02-22
$31.59M
6-K · filed 2019-02-22
2017-06-30$58.91M
20-F · filed 2019-09-09
2016-06-30$50.01M
20-F · filed 2018-08-31